Latest News and Press Releases

MIAMI, Nov. 10, 2021 (GLOBE NEWSWIRE) -- Mycotopia Therapies Inc. (OTC Pink: TPIA) (the “Company”) today announced the appointment of Saphire Longmore M.B.B.S., DM, to the role of Chief Medical...

MIAMI, Nov. 04, 2021 (GLOBE NEWSWIRE) -- Mycotopia Therapies Inc., (OTC Pink: TPIA) (the “Company”), announced today that Ben Kaplan, President, Chief Executive Officer and Chairman, has issued a...

MIAMI, Aug. 25, 2021 (GLOBE NEWSWIRE) -- Mycotopia Therapies, Inc. (OTC Pink: TPIA) (the “Company”), a company focused on psychedelic therapies, announced today it has entered into a Psilocybin...

MIAMI, July 14, 2021 (GLOBE NEWSWIRE) -- Mycotopia Therapies, Inc., (OTC Pink: TPIA) ("Mycotopia" or the “Company”) announced today that on July 13, 2021 Wesana Health Holdings Inc. (“Wesana”) (CSE:...

MIAMI, July 02, 2021 (GLOBE NEWSWIRE) -- Mycotopia Therapies, Inc., (OTC Pink: TPIA) (the “Company”) announced today an upcoming complimentary Psychedelic Industry summit will take place virtually...

MIAMI, May 04, 2021 (GLOBE NEWSWIRE) -- Mycotopia Therapies Inc., (OTC Pink: TPIA), a company focused on psychedelic therapies, announced today its name and symbol change are complete. Mycotopia...

MIAMI, May 04, 2021 (GLOBE NEWSWIRE) -- Mycotopia Therapies Inc., (OTC Pink: MYCO), a company focused on psychedelic therapies, announced today its name and symbol change are complete. Mycotopia...

MIAMI, March 22, 2021 (GLOBE NEWSWIRE) -- 20/20 Global, Inc. dba Mycotopia Therapies, (OTC Pink: TWGL) (the “Company”), a company focused on psychedelic therapies, announced today it has formed...

MIAMI, Feb. 08, 2021 (GLOBE NEWSWIRE) -- Mycotopia Therapies (20/20 Global, Inc.), (OTC Pink: TWGL), a company focused on psychedelic therapies, is establishing a biosynthetic compound subsidiary...

MIAMI, Feb. 08, 2021 (GLOBE NEWSWIRE) -- 20/20 Global, Inc., (OTC Pink: TWGL) “Mycotopia”, a company focused on psychedelic therapies, announced today that it has applied to the Financial Industry...